Table 1.
Patient Characteristics and Treatment
| Variable | Men n=31 050 | Women n=17 068 | Missing n (%) | P Value | P Value PS |
|---|---|---|---|---|---|
| Age, mean (SD) | 68±12 | 75±12 | — | <0.001 | 0.946 |
| STEMI, n (%) | 11 636 (39) | 5821 (35) | 1452 (3) | <0.001 | 0.923 |
| BMI, mean (±SD) | 269 (53) | 263 (68) | 25 313 (55) | <0.001 | 0.930 |
| Smoker, n (%) | 6978 (24) | 3162 (21) | 4200 (9) | <0.001 | 0.966 |
| Diabetes, n (%) | 5609 (18) | 3614 (21) | 400 (1) | <0.001 | 0.915 |
| Hypertension, n (%) | 11 488 (38) | 7982 (48) | 1221 (2) | <0.001 | 0.909 |
| Hyperlipidemia, n (%) | 3440 (14) | 1754 (13) | 551 (1) | 0.013 | 0.928 |
| Serum creatinine, mean (SD) | 104 (65) | 90 (52) | 20 471 (43) | <0.001 | 0.471 |
| LV function, n (%) | 17 088 | 8532 | 22 498 (47) | 0.155 | 0.911 |
| >50% | 9843 (58) | 4991 (59) | n/a | n/a | n/a |
| 40% to 49% | 3951 (23) | 1888 (22) | n/a | n/a | n/a |
| 30% to 39% | 2025 (12) | 1050 (12) | n/a | n/a | n/a |
| <30% | 1269 (7) | 603 (7) | n/a | n/a | n/a |
| Previous myocardial infarction, n (%) | 6196 (20) | 2890 (17) | 699 (1) | <0.001 | 0.968 |
| Previous PCI, n (%) | 1810 (6) | 629 (4) | 676 (1) | <0.001 | 0.939 |
| Previous cardiac surgery, n (%) | 2422 (8) | 705 (4) | 462 (1) | <0.001 | 0.988 |
| Reperfusion, n (%) | 10 878 (35) | 4734 (28) | 443 (1) | <0.001 | 0.856 |
| ASA after discharge, n (%) | 25 363 (84) | 13 397 (81) | 1426 (3) | <0.001 | 0.961 |
| Other antiplatelet at discharge, n (%) | 13 924 (46) | 6602 (40) | 1109 (2) | <0.001 | 0.985 |
| β-blocker at discharge, n (%) | 25 917 (85) | 13 591 (82) | 1117 (2) | <0.001 | 0.965 |
| ACEI or ARB at discharge, n (%) | 16 663 (55) | 8498 (51) | 1135 (2) | <0.001 | 0.988 |
| Oral anticoagulants at discharge, n (%) | 2897 (10) | 1262 (8) | 1163 (2) | <0.001 | 0.969 |
| Statins at discharge, n (%) | 18 907 (62) | 8698 (52) | 1158 (2) | <0.001 | 0.583 |
| IV diuretics during hospitalization, n (%) | 7784 (25) | 5761 (34) | 516 (1) | <0.001 | 0.161 |
| IV inotropes during hospitalization, n (%) | 1547 (5) | 865 (5) | 551 (1) | 0.674 | 0.139 |
| CPAP during hospitalization, n (%) | 1756 (6) | 1317 (8) | 572 (1) | <0.001 | 0.297 |
| Prehospital cardiogenic shock, n (%) | 1614 (5) | 1046 (6) | 1511 (3) | <0.001 | 0.941 |
| Prehospital cardiac arrest, n (%) | 586 (2) | 201 (1) | 2407 (5) | <0.001 | 0.861 |
| In-hospital heart failure, n (%) | 9388 (31) | 6816 (41) | 1833 (4) | <0.001 | 0.986 |
ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, acetylsalicylic acid; BMI, body mass-index; CPAP, continuous positive airway pressure; IV, intravenous; LV, left ventricle; PCI, percutaneous coronary intervention; PS, propensity score adjusted; STEMI, ST-segment elevation myocardial infarction.